Skip to main content
Loading navigation...
Ultibro Breezhaler

Ultibro Breezhaler

Manufacturer: Novartis Pharmaceuticals UK Limited

£64.99

Prescription required

Ultibro Breezhaler is a prescription-only maintenance inhalation treatment for adults with chronic obstructive pulmonary disease (COPD).

It contains two long-acting bronchodilators, indacaterol and glycopyrronium, which help keep the airways open and relieve ongoing breathing symptoms.

Ultibro Breezhaler is taken once daily using the supplied inhaler device.

It is not suitable for treating asthma or providing immediate relief during sudden breathing difficulties.

Treatment requires an appropriate clinical assessment and a valid prescription.

Each delivered dose contains:

  • Indacaterol 85 micrograms

  • Glycopyrronium 43 micrograms

Other ingredients include lactose monohydrate (contains milk proteins) and magnesium stearate.

WhatsApp